Skip to main content
Premium Trial:

Request an Annual Quote

Good Start Genetics, Genome Medical Form Genetic Counseling Partnership

NEW YORK (GenomeWeb) – Good Start Genetics announced today that it has signed an agreement under which genetic counseling support for its VeriYou carrier screening service will be provided by Genome Medical.

Specific terms of the deal were not disclosed.

VeriYou, which was launched in September, is a saliva-based test for prospective parents that uses next-generation sequencing to screen for genetic mutations associated with cystic fibrosis and spinal muscular atrophy. It is available through Good Start Genetics and Amazon.com.

"With the pace of innovation in genetics accelerating, it is essential to ensure that all test results — positive and negative — come with high-quality, affordable genetic counseling to ensure that patients and their physicians fully understand their meaning," Nicole Faulkner, medical director at Good Start Genetics, said in a statement. "I am thrilled to be able to amplify our world-class team via our partnership with Genome Medical."

The partnership announced today comes about a month after Good Start Genetics inked a deal to offer its GeneVu carrier screening test in combination with Roche Diagnostics' Harmony noninvasive prenatal fetal aneuploidy test.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.